Next Article in Journal
Effect of GABA, a Bacterial Metabolite, on Pseudomonas fluorescens Surface Properties and Cytotoxicity
Next Article in Special Issue
The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer
Previous Article in Journal
A Hamiltonian Replica Exchange Molecular Dynamics (MD) Method for the Study of Folding, Based on the Analysis of the Stabilization Determinants of Proteins
Previous Article in Special Issue
Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
Int. J. Mol. Sci. 2013, 14(6), 12170-12185; doi:10.3390/ijms140612170
Article

Serum Metallothioneins in Childhood Tumours — A Potential Prognostic Marker

1
,
2,3
,
2,3
,
2,3
,
4
,
1
 and
1,*
1 Department of Paediatric Haematology and Oncology, 2nd Medical Faculty and University Hospital Motol, V Uvalu 84, Prague CZ 150 06, Czech Republic 2 Department of Chemistry and Biochemistry, Faculty of Agronomy, Mendel University in Brno, Zemedelska 1, Brno CZ 613 00, Czech Republic 3 Central European Institute of Technology, Brno University of Technology, Technicka 3058/10, Brno CZ 616 00, Czech Republic 4 Department of Medical Chemistry and Clinical Biochemistry, 2nd Medical Faculty and University Hospital Motol, V Uvalu 84, Prague CZ 150 06, Czech Republic
* Author to whom correspondence should be addressed.
Received: 10 April 2013 / Revised: 22 May 2013 / Accepted: 30 May 2013 / Published: 6 June 2013
(This article belongs to the Special Issue Advances in Cancer Diagnosis)
View Full-Text   |   Download PDF [328 KB, uploaded 19 June 2014]   |   Browse Figures

Abstract

Metallothioneins (MT) are low molecular weight, cysteine-rich proteins maintaining metal ions homeostasis. They play a role in carcinogenesis and may also cause chemoresistance. The aim of the study was to explore the importance of MT serum levels in children suffering from malignant tumours. This prospective study involves examination of 865 samples from 172 patients with malignant tumours treated from 2008 to 2011 at University Hospital Motol. MT serum levels were determined using differential pulse voltammetry–Brdicka reaction. Mean MT level was 2.7 ± 0.5 μM. There was no statistically significant difference between MT levels in different tumours. We also did not find any correlation between MT levels and response to therapy or clinical stages. However, we found a positive correlation between MT levels and age (p = 0.009) and a negative correlation with absolute lymphocyte number (p = 0.001). The fact that patients who had early disease recurrence had lower MT levels during the treatment (complete remission 2.67 vs. recurring 2.34, p = 0.001) seems to be important for clinical practice. Accordingly we believe that there is benefit in further studies of serum MT levels in tumours.
Keywords: serum metallothioneins; children; solid tumours; treatment; differential pulse voltammetry Brdicka reaction serum metallothioneins; children; solid tumours; treatment; differential pulse voltammetry Brdicka reaction
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Kruseova, J.; Hynek, D.; Adam, V.; Kizek, R.; Prusa, R.; Hrabeta, J.; Eckschlager, T. Serum Metallothioneins in Childhood Tumours — A Potential Prognostic Marker. Int. J. Mol. Sci. 2013, 14, 12170-12185.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert